Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An integrated, scaled approach to resolve TSC2 variants of uncertain significance.

Nature communications·2026
Same author

Saturation Genome Editing reveals the functional impact of RAD51D <i>and</i> XRCC2 variants.

bioRxiv : the preprint server for biology·2026
Same author

Cognitive Decline, Neurologic Involvement, and Neonatal Crisis in <i>ABCC9</i>-Related Intellectual Disability and Myopathy Syndrome.

Neurology. Genetics·2026
Same author

Embryo-scale Visual Cell Sorting reveals a conserved transcriptomic signature of nucleolar size linked to proteostasis.

bioRxiv : the preprint server for biology·2026
Same author

Not Forgotten: Patient Experiences with Genetic Variant Reclassifications.

medRxiv : the preprint server for health sciences·2026
Same author

Gene- and domain-aware calibration increases the clinical utility of variant effect predictors.

Research square·2026

Related Experiment Video

Updated: Dec 22, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.9K

A Premalignant Cell-Based Model for Functionalization and Classification of PTEN Variants.

Jesse T Chao1, Rocio Hollman1, Warren M Meyers1

  • 1Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, Canada.

Cancer Research
|May 6, 2020
PubMed
Summary

A new cell-based assay and machine learning model accurately classify PTEN variants, aiding in differentiating benign from pathogenic mutations for cancer patients. This approach improves upon existing computational predictions for genetic variants.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

2.0K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.4K

Related Experiment Videos

Last Updated: Dec 22, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.9K
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

2.0K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.4K

Area of Science:

  • Oncology
  • Genetics
  • Biotechnology

Background:

  • Accurate classification of genetic variants in disease-associated genes like PTEN is crucial for patient management.
  • Many PTEN variants lack clear benign or pathogenic classifications, hindering clinical decision-making.
  • PTEN hamartoma tumor syndrome is linked to PTEN mutations, but recent variants require functional assessment.

Purpose of the Study:

  • To develop and validate a novel cell-based assay for functional characterization of PTEN variants.
  • To utilize machine learning to classify the pathogenicity of PTEN missense variants based on functional data.
  • To improve the annotation of clinical significance for PTEN variants, particularly those of uncertain significance.

Main Methods:

  • A cell-based assay using PTEN-null mammary epithelial cells to assess spheroid formation rescue by PTEN variants.
  • Functional assessment of 47 PTEN missense variants, with a focus on those lacking clear ClinVar classifications.
  • Application of a machine learning model trained on functional scores and genotypic data for variant classification.

Main Results:

  • The assay successfully functionalized 47 missense PTEN variants, classifying many previously uncharacterized ones.
  • The machine learning model achieved high accuracy in predicting variant pathogenicity based on functional data.
  • Reduced protein stability was identified as a potential mechanism for pathogenicity in certain PTEN variants.
  • The developed assay demonstrated superior performance, scalability, and speed compared to computational prediction methods.

Conclusions:

  • The combined 3D tumor spheroid modeling and machine learning approach effectively classifies PTEN missense variants.
  • This assay provides a robust and scalable alternative for annotating the clinical significance of cancer-associated PTEN variants.
  • The findings will aid in distinguishing benign from pathogenic PTEN variants, facilitating appropriate patient care and surveillance.